|Title||Changing From Stavudine to Tenofovir in First-Line Antiretroviral Therapy in South Africa|
|Authors||Alana Brennan, Kate Shearer, & Matthew Fox|
|Publisher||HE2RO Policy Brief Number 4, Health Economics and Epidemiology Research Office|
Since 2010, the Health Economics and Epidemiology Research Office (HE2RO) has conducted a series of observational studies designed to assess the impact of the change to tenofovir in first-line ART. Each of these studies was done at the Themba Lethu Clinic, a large HIV treatment clinic in Johannesburg, South Africa. The results of three of these studies are summarized in this policy brief.
|Full Text||Download Document|